101. Spotlight on combination therapy development: strategic directions towards improving current I-O response rates. Issue 5 (2022) Authors: Daud, Adil; Haugh, Alexandra; Jacob, Saya Journal: Immuno-oncology insights Issue: Volume 3:Issue 5(2022) Page Start: 285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
102. Spotlight on optimizing clinical development strategy. Issue 3 (2022) Authors: O'Donnell-Tormey, Jill Journal: Immuno-oncology insights Issue: Volume 3:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
103. Strategies to enhance immune cell activation & cancer cell killing. Issue 11 (2022) Authors: Pinchbeck, Abigail; Breckpot, Karine Journal: Immuno-oncology insights Issue: Volume 3:Issue 11(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
104. T cell characterization in 3D cell models using advanced flow cytometry. Issue 4 (2021) Authors: Oliver, Miniver Journal: Immuno-oncology insights Issue: Volume 2:Issue 4(2021) Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
105. T cell immunotherapy: addressing toxicity issues in arapidly commercializing field. Issue 3 (2020) Authors: ROSSI, JOHN Journal: Immuno-oncology insights Issue: Volume 1:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
106. Taking the initiative to advance precision medicine: a perspective from Norway. Issue 7 (2022) Authors: McGuigan, Ròisin Journal: Immuno-oncology insights Issue: Volume 3:Issue 7(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
107. The changing landscape of cancer vaccines: developing in situ vaccination. Issue 11 (2022) Authors: Pinchbeck, Abigail; Brody, Joshua Journal: Immuno-oncology insights Issue: Volume 3:Issue 11(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
108. The concept of 'iatrogenic resistance': insights into mechanisms of induction of resistance to immune checkpoint blockade in combination immunotherapy. Issue 1 (2020) Authors: Gupta, Seema; Khleif, Samir N Journal: Immuno-oncology insights Issue: Volume 1:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
109. The cutting edge: leveraging pre-surgical immunotherapy trials to understand therapeutic mechanisms. Issue 3 (2022) Authors: Fitzgerald, Bailey G; Galsky, Matthew D; Marron, Thomas U Journal: Immuno-oncology insights Issue: Volume 3:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
110. The end of an era of cancer drug discovery: life without new drug targets. Issue 4 (2022) Authors: Mardiros, Armen; Kamb, Alexander Journal: Immuno-oncology insights Issue: Volume 3:Issue 4(2022) Page Start: 190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗